229 related articles for article (PubMed ID: 35123465)
1. Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report.
Ye X; Yang J; Stebbing J; Peng L
BMC Pulm Med; 2022 Feb; 22(1):54. PubMed ID: 35123465
[TBL] [Abstract][Full Text] [Related]
2. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer.
Ding X; Ji W; Li J; Zhang X; Wang L
Radiat Oncol; 2011 Mar; 6():24. PubMed ID: 21375774
[TBL] [Abstract][Full Text] [Related]
3. Pembrolizumab-induced Radiation Recall Pneumonitis After the Resolution of Typical Asymptomatic Radiation Pneumonitis.
Itamura H; Ohguri T; Yahara K; Nakahara S; Kakinouchi S; Morisaki T; Yatera K; Tanaka F; Korogi Y
J UOEH; 2020; 42(3):261-266. PubMed ID: 32879190
[TBL] [Abstract][Full Text] [Related]
4. Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review.
Awad R; Nott L
Asia Pac J Clin Oncol; 2016 Mar; 12(1):91-5. PubMed ID: 26846159
[TBL] [Abstract][Full Text] [Related]
5. Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer.
Cousin F; Desir C; Ben Mustapha S; Mievis C; Coucke P; Hustinx R
Radiother Oncol; 2021 Apr; 157():47-55. PubMed ID: 33453313
[TBL] [Abstract][Full Text] [Related]
6. Radiation recall pneumonitis induced by epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced nonsmall-cell lung cancer.
Chiang CL; Chen YW; Wu MH; Huang HC; Tsai CM; Chiu CH
J Chin Med Assoc; 2016 May; 79(5):248-55. PubMed ID: 27036494
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer.
Lu X; Wang J; Zhang T; Zhou Z; Deng L; Wang X; Wang W; Liu W; Tang W; Wang Z; Wang J; Jiang W; Bi N; Wang L
Front Immunol; 2022; 13():918787. PubMed ID: 35795657
[TBL] [Abstract][Full Text] [Related]
8. Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study.
Jang JY; Kim SS; Song SY; Kim YJ; Kim SW; Choi EK
Radiat Oncol; 2021 Dec; 16(1):231. PubMed ID: 34863244
[TBL] [Abstract][Full Text] [Related]
9. Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications.
Teng F; Li M; Yu J
BMC Med; 2020 Sep; 18(1):275. PubMed ID: 32943072
[TBL] [Abstract][Full Text] [Related]
10. Re-irradiation in locally recurrent lung cancer patients.
Schlampp I; Rieber J; Adeberg S; Bozorgmehr F; Heußel CP; Steins M; Kappes J; Hoffmann H; Welzel T; Debus J; Rieken S
Strahlenther Onkol; 2019 Aug; 195(8):725-733. PubMed ID: 30937509
[TBL] [Abstract][Full Text] [Related]
11. Radiation Recall Pneumonitis Induced by Sintilimab: A Case Report and Literature Review.
Wang M; Xu S; Zhu H
Front Immunol; 2022; 13():823767. PubMed ID: 35280981
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of pneumonitis following chemoradiotherapy and immunotherapy in stage III non-small cell lung cancer.
Smesseim I; Mets OM; Daniels JMA; Bahce I; Senan S
Radiother Oncol; 2024 May; 194():110147. PubMed ID: 38341099
[TBL] [Abstract][Full Text] [Related]
13. Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.
Fukui T; Hosotani S; Soda I; Ozawa T; Kusuhara S; Kakegawa MI; Kasajima M; Hiyoshi Y; Igawa S; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Ishiyama H; Naoki K
Thorac Cancer; 2020 Apr; 11(4):1005-1014. PubMed ID: 32057187
[TBL] [Abstract][Full Text] [Related]
14. Ultra-central Thoracic Re-irradiation Using 10-fraction Stereotactic Body Radiotherapy for Recurrent Non-small-cell Lung Cancer Tumors: Preliminary Toxicity and Efficacy Outcomes.
Sood S; Ganju R; Shen X; Napel MT; Wang F
Clin Lung Cancer; 2021 May; 22(3):e301-e312. PubMed ID: 33132058
[TBL] [Abstract][Full Text] [Related]
15. Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.
Nieder C; De Ruysscher D; Gaspar LE; Guckenberger M; Mehta MP; Cheung P; Sahgal A
Strahlenther Onkol; 2017 Jul; 193(7):515-524. PubMed ID: 28424839
[TBL] [Abstract][Full Text] [Related]
16. Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT.
Ogawa Y; Shibamoto Y; Hashizume C; Kondo T; Iwata H; Tomita N; Ogino H
Radiat Oncol; 2018 Jul; 13(1):136. PubMed ID: 30055636
[TBL] [Abstract][Full Text] [Related]
17. Challenges in Re-Irradiation in the Thorax: Managing Patients with Locally Recurrent Non-Small Cell Lung Cancer.
Fischer-Valuck BW; Robinson CG; Simone CB; Gomez DR; Bradley JD
Semin Radiat Oncol; 2020 Jul; 30(3):223-231. PubMed ID: 32503787
[TBL] [Abstract][Full Text] [Related]
18. Rapid Development of Clinically Symptomatic Radiation Recall Pneumonitis Immediately Following COVID-19 Vaccination.
Steber CR; Ponnatapura J; Hughes RT; Farris MK
Cureus; 2021 Apr; 13(4):e14303. PubMed ID: 33968515
[TBL] [Abstract][Full Text] [Related]
19. Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer.
Torresan S; Zussino G; Cortiula F; Follador A; Fasola G; Girometti R; Cereser L
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835802
[TBL] [Abstract][Full Text] [Related]
20. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
Ren C; Ji T; Liu T; Dang J; Li G
Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
